Annual Cash & Cash Equivalents:
$66.34M+$19.62M(+42.00%)Summary
- As of today, SBRA annual cash & cash equivalents is $66.34 million, with the most recent change of +$19.62 million (+42.00%) on December 31, 2024.
- During the last 3 years, SBRA annual cash & cash equivalents has fallen by -$49.55 million (-42.75%).
- SBRA annual cash & cash equivalents is now -88.71% below its all-time high of $587.45 million, reached on December 31, 2017.
Performance
SBRA Cash and Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly Cash & Cash Equivalents:
$207.52M+$105.87M(+104.15%)Summary
- As of today, SBRA quarterly cash & cash equivalents is $207.52 million, with the most recent change of +$105.87 million (+104.15%) on September 30, 2025.
- Over the past year, SBRA quarterly cash & cash equivalents has increased by +$138.54 million (+200.86%).
- SBRA quarterly cash & cash equivalents is now -64.67% below its all-time high of $587.45 million, reached on December 31, 2017.
Performance
SBRA Quarterly Cash & Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash and Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
SBRA Cash and Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1Y1 Year | +42.0% | +200.9% |
| 3Y3 Years | -42.8% | +566.2% |
| 5Y5 Years | +35.0% | +395.9% |
SBRA Cash and Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | |
|---|---|---|---|---|---|
| 3Y | 3-Year | -42.8% | +42.0% | at high | +618.1% |
| 5Y | 5-Year | -42.8% | +42.0% | -62.4% | +618.1% |
| All-Time | All-Time | -88.7% | +586.7% | -64.7% | +2211.4% |
SBRA Cash and Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2025 | - | $207.52M(+104.1%) |
| Jun 2025 | - | $101.65M(+251.8%) |
| Mar 2025 | - | $28.90M(-56.4%) |
| Dec 2024 | $66.34M(+42.0%) | $66.34M(-3.8%) |
| Sep 2024 | - | $68.98M(+63.0%) |
| Jun 2024 | - | $42.31M(-35.8%) |
| Mar 2024 | - | $65.93M(+41.1%) |
| Dec 2023 | $46.72M(-13.4%) | $46.72M(+20.2%) |
| Sep 2023 | - | $38.86M(+20.0%) |
| Jun 2023 | - | $32.38M(-16.3%) |
| Mar 2023 | - | $38.68M(-28.3%) |
| Dec 2022 | $53.93M(-53.5%) | $53.93M(+73.1%) |
| Sep 2022 | - | $31.15M(-56.4%) |
| Jun 2022 | - | $71.52M(+144.3%) |
| Mar 2022 | - | $29.28M(-74.7%) |
| Dec 2021 | $115.89M(+76.9%) | $115.89M(-79.0%) |
| Sep 2021 | - | $551.42M(+645.8%) |
| Jun 2021 | - | $73.94M(+150.7%) |
| Mar 2021 | - | $29.49M(-55.0%) |
| Dec 2020 | $65.52M(+33.3%) | $65.52M(+56.6%) |
| Sep 2020 | - | $41.85M(+13.7%) |
| Jun 2020 | - | $36.80M(-41.0%) |
| Mar 2020 | - | $62.43M(+27.0%) |
| Dec 2019 | $49.14M(-17.6%) | $49.14M(+23.9%) |
| Sep 2019 | - | $39.66M(-31.0%) |
| Jun 2019 | - | $57.47M(+76.1%) |
| Mar 2019 | - | $32.64M(-45.3%) |
| Dec 2018 | $59.66M | $59.66M(-57.2%) |
| Sep 2018 | - | $139.52M(-38.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2018 | - | $225.65M(+287.9%) |
| Mar 2018 | - | $58.17M(-90.1%) |
| Dec 2017 | $587.45M(+1594.6%) | $587.45M(+1254.8%) |
| Sep 2017 | - | $43.36M(+91.5%) |
| Jun 2017 | - | $22.65M(+3.1%) |
| Mar 2017 | - | $21.96M(-36.6%) |
| Dec 2016 | $34.66M(+101.0%) | $34.66M(+20.3%) |
| Sep 2016 | - | $28.82M(-74.5%) |
| Jun 2016 | - | $112.85M(+530.2%) |
| Mar 2016 | - | $17.91M(+3.8%) |
| Dec 2015 | $17.25M(-74.9%) | $17.25M(-56.6%) |
| Sep 2015 | - | $39.71M(+202.3%) |
| Jun 2015 | - | $13.13M(+18.1%) |
| Mar 2015 | - | $11.12M(-83.8%) |
| Dec 2014 | $68.82M(+612.4%) | $68.82M(+114.9%) |
| Sep 2014 | - | $32.02M(+50.9%) |
| Jun 2014 | - | $21.21M(+0.3%) |
| Mar 2014 | - | $21.15M(+118.9%) |
| Dec 2013 | $9.66M(-55.5%) | $9.66M(-90.7%) |
| Sep 2013 | - | $103.45M(+5.0%) |
| Jun 2013 | - | $98.51M(+67.4%) |
| Mar 2013 | - | $58.84M(+171.3%) |
| Dec 2012 | $21.69M(-48.7%) | $21.69M(-39.2%) |
| Sep 2012 | - | $35.67M(+250.2%) |
| Jun 2012 | - | $10.19M(+9.1%) |
| Mar 2012 | - | $9.34M(-85.1%) |
| Dec 2011 | $42.25M | - |
| Sep 2011 | - | $62.70M(+598.4%) |
| Jun 2011 | - | $8.98M(-89.5%) |
| Mar 2011 | - | $85.74M |
FAQ
- What is Sabra Health Care REIT, Inc. annual cash & cash equivalents?
- What is the all-time high annual cash & cash equivalents for Sabra Health Care REIT, Inc.?
- What is Sabra Health Care REIT, Inc. annual cash & cash equivalents year-on-year change?
- What is Sabra Health Care REIT, Inc. quarterly cash & cash equivalents?
- What is the all-time high quarterly cash & cash equivalents for Sabra Health Care REIT, Inc.?
- What is Sabra Health Care REIT, Inc. quarterly cash & cash equivalents year-on-year change?
What is Sabra Health Care REIT, Inc. annual cash & cash equivalents?
The current annual cash & cash equivalents of SBRA is $66.34M
What is the all-time high annual cash & cash equivalents for Sabra Health Care REIT, Inc.?
Sabra Health Care REIT, Inc. all-time high annual cash & cash equivalents is $587.45M
What is Sabra Health Care REIT, Inc. annual cash & cash equivalents year-on-year change?
Over the past year, SBRA annual cash & cash equivalents has changed by +$19.62M (+42.00%)
What is Sabra Health Care REIT, Inc. quarterly cash & cash equivalents?
The current quarterly cash & cash equivalents of SBRA is $207.52M
What is the all-time high quarterly cash & cash equivalents for Sabra Health Care REIT, Inc.?
Sabra Health Care REIT, Inc. all-time high quarterly cash & cash equivalents is $587.45M
What is Sabra Health Care REIT, Inc. quarterly cash & cash equivalents year-on-year change?
Over the past year, SBRA quarterly cash & cash equivalents has changed by +$138.54M (+200.86%)